February 28, 2019
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
AGTC posts quarterly net loss
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Applied Genetic Technologies Corporation reported a net loss of $4.2 million, or $0.23 per share, in its second fiscal quarter ended Dec. 31, 2018, compared with a net loss of $5.2 million, or $0.29 per share, in the same quarter a year ago.
Total revenue was $5.9 million for the quarter compared with $4.9 million the previous year, according to a press release.
Research and development expenses totaled $7.6 million, while general and administrative expenses were $3 million.
AGTC had $96.1 million in cash, cash equivalents and investments as of Dec. 31.